GL1X · GenesisL1 explorer

MolNFT v1 · #20426 · protein

Endo-1,4-beta-xylanase II complex with 2,3-epoxypropyl-beta-D-xyloside

1REF: “Endo-1,4-beta-xylanase II complex with 2,3-epoxypropyl-beta-D-xyloside”. X-ray diffraction, 2 ligands (BEZ, C3X), 3 pockets (best druggability 0.55). MolNFT v1 #20426 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1REF
Type
protein
Length
380 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endo-1,4-beta-xylanase II
EC
3.2.1.8
UniProt
P36217
Ligands
BEZ, C3X
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 61% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEndo-1,4-beta-xylanase II (EC 3.2.1.8)protein1905% helix, 61% strandP36217

Ligands and binding sites

  • BEZ · Benzoic acid · ligand · chains B
  • C3X · (2R)-oxiran-2-ylmethyl beta-D-xylopyranoside · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12240.550.7836C3X
22380.470.7335empty
3540.330.7819empty

Interfaces

1 interface between chains.

  • A–B · 187 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (cyclization, covalent ligand).

Compared structures

  • 1REF · Endo-1,4-beta-xylanase II complex with 2,3-epoxypropyl-beta-D-xyloside · the same entry in another collection · chain A against A, TM-score 1.00
  • P36217 · AlphaFold monomer V2.0 prediction for endo-1,4-beta-xylanase 2 (P36217) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.